News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,488 Results
Type
Article (5051)
Company Profile (18)
Press Release (219419)
Section
Business (82533)
Career Advice (462)
Deals (15073)
Drug Delivery (8)
Drug Development (19331)
Employer Resources (30)
FDA (3717)
Job Trends (3909)
News (120765)
Policy (7546)
Tag
Academia (301)
Alliances (14898)
Alzheimer's disease (228)
Approvals (3723)
Artificial intelligence (30)
Bankruptcy (95)
Best Places to Work (2867)
Breast cancer (42)
Cancer (353)
Career advice (392)
Cell therapy (80)
Clinical research (16005)
Collaboration (125)
Compensation (106)
COVID-19 (299)
C-suite (69)
Data (383)
Diabetes (30)
Diagnostics (2027)
Earnings (40191)
Employer resources (31)
Events (37491)
Executive appointments (223)
FDA (3892)
Funding (142)
Gene therapy (37)
GLP-1 (102)
Government (414)
Healthcare (5078)
Infectious disease (311)
Inflammatory bowel disease (24)
Interviews (53)
IPO (7803)
Job creations (1121)
Job search strategy (361)
Layoffs (99)
Legal (2337)
Lung cancer (39)
Manufacturing (38)
Medical device (3881)
Medtech (3882)
Mergers & acquisitions (7394)
Metabolic disorders (94)
Neuroscience (295)
NextGen: Class of 2025 (1679)
Non-profit (733)
Northern California (678)
Obesity (45)
Opinion (29)
People (24442)
Phase I (4799)
Phase II (6974)
Phase III (5497)
Pipeline (320)
Postmarket research (626)
Preclinical (1955)
Press Release (66)
Radiopharmaceuticals (105)
Rare diseases (57)
Real estate (1877)
Regulatory (5075)
Research institute (304)
Resumes & cover letters (68)
Southern California (513)
Startups (1019)
United States (5358)
Vaccines (30)
Date
Last 7 days (156)
Last 30 days (731)
Last 365 days (10874)
2025 (757)
2024 (11125)
2023 (13309)
2022 (18843)
2021 (19844)
2020 (18356)
2019 (13283)
2018 (10281)
2017 (10114)
2016 (9265)
2015 (12218)
2014 (9633)
2013 (7744)
2012 (8379)
2011 (8847)
2010 (8667)
Location
Africa (182)
Arizona (52)
Asia (11533)
Australia (1603)
California (1422)
Canada (567)
China (46)
Colorado (64)
Connecticut (72)
Europe (24490)
Florida (187)
Georgia (27)
Illinois (90)
Indiana (46)
Japan (45)
Kansas (24)
Maine (36)
Maryland (167)
Massachusetts (1177)
Michigan (75)
Minnesota (117)
New Jersey (420)
New York (375)
North Carolina (269)
Northern California (678)
Ohio (43)
Pennsylvania (278)
South America (274)
Southern California (513)
Texas (174)
Utah (43)
Virginia (29)
Washington State (124)
224,488 Results for "invivo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Small Animal Imaging (In-Vivo) Market Expecting a Surge in Revenue of US$ 1,902 Million By 2032
The global small animal imaging (In-Vivo) market was valued at US$ 1,053 million in 2023.
May 2, 2024
·
7 min read
Deals
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
February 6, 2024
·
3 min read
Press Releases
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
December 10, 2024
·
3 min read
Press Releases
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024
·
7 min read
Genetown
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold™, a bioresorbable scaffold-based device in development for patients with acute SCI.
March 9, 2023
·
3 min read
Pharm Country
Nuvectis Pharma Announces a Publication in The Journal of Experimental Medicine for NXP900 in an In-Vivo Model of Metastatic Castration Resistant Prostate Cancer (“mCRPC”) with Acquired Resistance to Enzalutamide
Nuvectis Pharma, Inc. today announced a publication in the Journal of Experimental Medicine (“JEM”) for NXP900 in an in-vivo model of metastatic castration resistant prostate cancer.
February 9, 2023
·
4 min read
Deals
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
InVivo Therapeutics Holdings Corp. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the sale and issuance of 523,810 shares of the Company’s common stock.
October 7, 2022
·
6 min read
Press Releases
Kelyniam Corporate Update
January 21, 2025
·
2 min read
Biotech Beach
Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™"
Zavation Medical Products, an innovative designer and manufacturer of spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the results of its novel LABYRINTH™ technology in an In-Vitro and In-Vivo research project.
August 10, 2022
·
3 min read
1 of 22,449
Next
